3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 3.150
-0.170 (-5.12%)
May 7, 2026, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 772.96 million as of May 7, 2026. Its market cap has decreased by -8.30% in one year.
Market Cap
772.96M
Enterprise Value
397.97M
Revenue
396.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.15
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 772.96M, a decrease of -88.99%. That is a compound annual growth rate of -47.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 814.68M | -37.71% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.58B |
| CANbridge Pharmaceuticals | 1.28B |
| Shanghai Bio-heart Biological Technology | 1.11B |
| Sunho Biologics | 970.43M |
| Brii Biosciences | 959.94M |
| Transcenta Holding | 953.77M |
| JW (Cayman) Therapeutics Co. | 953.25M |
| Wuhan YZY Biopharma | 891.71M |